The authors proposed an intraventricular 'floating' electrode inserted in the third ventricle (V3) adjacent to the ventromedian hypothalamus (VMH) in a freely moving Macaca fascicularis to modulate food intake (FI), body fat (BF), body weight (BW) and body mass index (BMI), as a potential treatment of obesity. METHODS: Five adult Macaca fascicularis monkeys were implanted stereotactically in the V3 contiguous to the VMH with one deep brain stimulation (DBS) electrode. The study was divided in two phases: (a) acute 24 h-fasting trials: different electrical stimulation parameters were applied to a fasting primate to determine the best combination in reducing FI; and (b) chronic 8-week stimulation trials: three cycles of intraventricular-VMH DBS lasting 8 --10 weeks were performed at 130 Hz, 80 Hz (most effective frequency reducing FI) and 30 Hz, respectively. BMI, BW, BF content, skinfolds and hormones were measured during baseline and at the end of each session of stimulation. RESULTS: Acute 24 h-fasting trials: there was a decrease in FI in all subjects at 80 Hz, (11 --19%, mean 15%). Chronic 8-week stimulation trials: a significant decrease in BW and BMI was observed in three out of four monkeys at 80 Hz (mean 8 ± 4.4%). Subcutaneous skinfolds were reduced in all four subjects at 80 Hz and slightly increased at 130 Hz. The sham monkey remained stable. No significant adverse effects were recorded. CONCLUSION: The stimulation of the VMH region through an intraventricular approach might acutely modulate FI and induce a sustained decrease in BW and fat mass in normal non-human primate.
INTRODUCTION
Obesity is a complex disorder that has reached epidemic proportions globally, with more than 1 billion adults overweight, according to WHO. It is associated with diminished quality of life 1 and reduces life expectancy. 2 Treatment includes non-pharmacological measures, drugs and surgical therapy. The use of pharmacological agents has demonstrated only discreet body weight (BW) reduction in controlled trials. For the surgery, some patients with morbid obesity still remain poor candidates for standard gastric bypass: complications occur in 15 --55% of bariatric patients, and the peri-surgical mortality rate is about 1.5% even in experienced centers. 3 Safer procedures, such as laparoscopic adjustable banded gastroplasty, are simpler but are not as effective. 4, 5 Large room for effective and safer procedures still exists.
Recently, modulation of brain circuits has emerged as a valuable clinical and research strategy in obesity. With the development of new hardware and electrophysiological techniques, deep brain stimulation (DBS) have been used for treating movement disorder, 6 pain, 7 obsessive compulsive disorders 8 --10 and clinical refractory epilepsy. 11, 12 A recent report on the hypothalamic DBS applied in cases of chronic intractable cluster headaches 13 has revived the interest in the hypothalamic region, which is also wellknown to be involved in food intake (FI) and energy balance regulation. DBS is a reversible, safe and adaptable technique that potentially allows new targets, such as the hypothalamic nuclei, to be explored in an attempt to extend therapeutical options for weight disorders. The purpose of the present study was to assess the effects of chronic ventromedian hypothalamic (VMH) stimulation on FI, body fat (BF) and BW in the primate using a new intraventricular approach to the VMH. Results will be used to assess the feasibility of using such stimulation as a potential therapy for cases of morbid obesity.
MATERIALS AND METHODS
Five normal weight Macaca fascicularis monkeys were acclimated to two daily meals. Four were implanted: two with 1.5 mm/four contact electrodes and two with 3.5 mm/one contact electrode, in the third ventricle (V3) at the level of the VMH. The sham monkey was implanted with 1.5 mm/four contact electrodes in the V3 but not connected to the implantable pulse generator. The laboratory is authorized by the French Ministry of Environment (Agreement No. B3851610003) and all experiments were performed in accordance with the European Communities Council Directive of 1986 (86/609/EEC) for care of laboratory animals. All participants had received certification for animal experimentation. Every effort was made to minimize animal suffering, while maximizing data output.
Surgery
Each animal was anesthetized using Ketamine (Imalgene, MERIAL, Lyon, France) followed by the administration of diazepam, in addition to 1% lidocaine with epinephrine for local anesthesia. The DBS electrode was introduced under fluoroscopy reaching directly anterior V3, adjacent to VMH (Figure 1 ).
EXPERIMENTAL DESIGN

Acute phase
Acute phase was designed to identify electrical settings that were effective in reducing the amount of FI and to asses the potential side effects of each contact using different stimulation parameters. After a period of 24 h fasting, the animal received 8 hours of DBS using different frequencies and voltage intensities. Each trial was separated for at least 48 h to 5 days. Further, a full day standard meal was presented between 1700 and 1800 hours. The feeding time and total amount of food consumed were recorded. Motor activity during stimulation was also recorded and video taped for further analysis (Noldus Ethovision Software, Wageningen, the Netherlands). Each animal underwent control sessions in which meals were presented in the same conditions but off-stimulation. The combination of parameters that reduce meal size without unacceptable side effects (best parameter settings or BPS) along with low (30 Hz) and high frequencies (130 Hz) stimulation were selected for chronic stimulation.
Chronic phase
Chronic phase was designed to assess the effects of intraventricular continuous VMH stimulation on FI, BF and BW, using crossover analysis. Animals received continuous stimulations day/ night for 8 weeks; in monopolar fashion. Three types of frequencies were used dividing the monkeys in two groups: first group (n ¼ 2) received 80 Hz, second received 130 Hz for duration of 8 weeks. A wash out period (WO) equivalent to half a length of the stimulation was done (4 weeks). Then the first two received 130 Hz and the others received 80 Hz. Other 4 weeks WO followed and a final 30 Hz stimulation were done for all the four monkeys ( Figure 2 ). During this phase, animals were weighed once a week and BF measured by bioimpedance analysis using Xitron bioimpedancemeter (Xitron, San Diego, CA, USA). Waist circumference, iliac and subcutaneous skinfolds and blood samples were also obtained. At the end of the protocol, 3 T MRI brain scanning (Brucker Biospin, Wissembourg, France) were performed followed by standard histological analysis. Coronal cuts were compared with Paxinos atlas for Macaca mulatta 16 for structural identification.
Statistical analysis
We used for the acute trials, the test non --parametric, non-paired of Kruskal --Wallis for multiple comparisons, and for chronic trials, Friedman's test paired non-parametric both followed by a post hoc Dunn's test. Measures were transformed in ratios, representing % of variation from baseline.
RESULTS
Acute phase
After acute stimulation of each animal, we found that during 80 Hz stimulation, 2 V, monopolar stimulation and lower contact (0), the meal size was reduced to 0.85 ± 0.04 of the baseline value (Po0.05) in all monkeys. Eating time remained unchanged. Velocity (cm s À1 ) increased at low frequencies (o130 Hz) with a peak at 80 Hz in three subjects (Figure 3 ). ). This approach, widely used in humans 14 and adapted for monkeys, 15 is quite valuable when targeting periventricular areas. Ventriculography was performed using a rigid catheter coupled with an electrode holder (Kopf instruments) that was lowered 16 --20 mm below the surface of the cortex, to enter the lateral ventricle. About 2 ml Iopamiron was injected swiftly after 0.5 ml of confirmatory air and AP/lateral X-rays were obtained. The sham monkey increased 4% BW during the duration of the experiment (32 weeks). There was a tendency to gain weight during the stimulations that were ineffective (other than 80 Hz). BW increased at 130 Hz to 2% ±2.5 and at 30 Hz (5% ±3). This difference was not significant (Figure 4 ).
Changes in FI and glucose during chronic stimulation A significant increase in FI was observed in subjects during WO period after BPS stimulation (80 Hz) (1.29±0. 12, Po0.05). This hyperphagia lasted 3 weeks, descending sharply at the end of WO (0.90 ± 0.10 at week 14) and then keeping around baseline during the rest of the trials. The sham monkey had a tendency to increase FI through the study.
During the first WO period, after effective BW loss (80 Hz), blood samples showed an increase in plasma glucose to 0.68 G/l (Po0.05). This rise in plasmatic glucose occurred during the hyperphagic period when animals regained BW after effective 80 Hz stimulation. Glucose maintained low normal values during the rest of the study (reference values for Macaca 0.66±0.15) ( Figure 5 ).
Changes in hormones and laboratory measures during stimulation For the corticotropic axis (growth hormone, cortisol) differences found were not statistically significant. For the thyrotrophic axis (thyrotrophin-stimulating hormone, T3 (triiodothyronine) and T4 (3, 5, 3 0 , 5 0 -tetraiodothyronine)), free T3 had a tendency to increase at 30 Hz stimulation (P ¼ 0.056). Free T4 presented almost no variation between different frequencies stimulation. Finally, the gonadotropic axis (prolactin, FSH, lateral hypothalamus (LH) and testosterone) presented high variability in the levels of prolactin; levels of LH were non-detectable in two monkeys and there was a tendency to increase the levels of testosterone during stimulation (P ¼ 0.056). Observed differences were not significant. Electrolytes
Changes in leptin during stimulation Great variability in levels of leptin was observed during the experiment, even in the non-stimulated sham subject. Observed differences were not statistically significant. The sham monkey had higher levels of leptin given its superior body mass index (BMI). After the end of the experiment, all subjects experienced an increase in absolute leptin levels.
Comparison in BW and BF using different electrode geometry Two animals underwent stimulation using contact (deepest contact) of the electrode 3389 Medtronic (Minneapolis, MN, USA), which is 1.5 mm in height, and the other two received stimulation through a contact of 3.5 mm in height, using the electrode 3388 Medtronic. Considering this difference, we analyzed the influences over weight. During effective BW reduction stimulation at 80 Hz, the contact 1.5 mm produced 0.89 ± 0.018 (11%) reduction in BW/BMI in monkeys after 8 weeks of continuous stimulation, meaning an additional 6% BW loss in comparison to that produced by the 3.5 mm electrode ( Figure 6 ).
LOCALIZATION: MRI SCANNING AND HISTOLOGICAL ANALYSIS RESULTS
All the contacts lied inside the 3 V. The lateral coordinates of the tip of the contact ranged between 0 and 0.55 mm from the midline, with the exception of the sham monkey, who was at 2.6 mm from the midline. The coordinates of the depth of the contact relative to the ac-pc plane ranged between 4.34 and 6.03 mm. The Y coordinates ranged between 0 and À1.53 mm posterior to the anterior commisure. Histological data showed the deepest contact at the level of VMH dorsal part. Both ventricular walls were deformed by the electrode geometry, without producing mechanical disruption to the tissue ( Figure 6 ).
DISCUSSION
BW and BF modulation
The most important finding of this study is that BW and BF can be modulated in primates using the adequate electrical stimulation (ES) parameters in the hypothalamic medial region. Animals reduced BW by 8% and reduced BF by 17 --19% at the end of 8 weeks after stimulation at 80 Hz. Other frequencies produced no significant changes. The tendency to gain weight during ineffective stimulation was probably because of certain amount of rebound weight gain and the effect of large time of captivity shown also in the sham monkey, which increased 4% weight during a 32-week period of observation.
The reduction in BW was primarily due to decreased fat mass observed in the abdomen or iliac region. The reduction in BW was done primarily in BF and was achieved in the local areas where BF accumulates, like the abdomen or iliac region. On the contrary, Each point is the average of four stimulated monkeys. Total blood glucose is represented in G/L and food intake is expressed as ratio (n/baseline) (*Po0.05).
subscapular fat was not changed during the experiment. Localized abdominal fat reduction was related in humans with reduction in the risk of obesity-associated diseases like hypertension or diabetes.
17,18
Several authors have showed modulation in BW in rats following lesion of lateral structures in the hypothalamus or ES in VMH. 19 --22 But the results in monkeys are limited and far from definite, 23 and only conflict reports have been published 24 in the sixties. The contradictory reports in monkeys possibly have a methodological reason. For the most part, authors use stimulation parameters coming from the basal ganglia stimulation in Parkinson's patients. 25 In contrast, VMH ES may require different stimulation parameters due to the complexity of the region. In our study, the acute stimulation protocol allowed to set parameters according to reduction in FI. This period of testing might be essential to produce effective BW reduction.
Another element in published studies that contrast with the present work was the observation period. Very short protocols 23 produced modulation in FI but failed to show BW loss. The present work used longer periods of stimulation, between 8 and 10 weeks with washout of 4 weeks. Extended periods of stimulation are sometime required in several disorders to achieve maximum benefit. 26, 27 A final element that distinguishes this study from others is the targeting and final active contact position. Targeting the VMH in the literature is performed by placing the electrode directly in the center of the nucleus. The difficulty with this approach is that it is easy to modulate subareas in the hypothalamus that are involved in opposite functions; as for example, the LH region. Indeed, ES of the LH can lead to BW gain and accumulation of BF. 28 Intraventricular stimulation has the advantage of covering medial hypothalamic areas, such as the VMH, but also the dorsomedian hypothalamic region and the paraventricular nucleus, avoiding antagonist lateral hypothalamic effects. 29 Modification in FI FI was stable during the chronic phase. However, during offstimulation period (washout), after effective BW loss and reduction in BF, there was an increase of 29% in FI (Po0.05). Hyperphagia was accompanied by an increase in glucose and rebound BW gain. Literature in obesity usually finds periods of hyperphagia and rebound BW gain after effective BW loss. 30, 31 During the acute-phase tests showed decrease FI in hungry monkeys at a precise frequency. Those parameters that induced reduction in FI during acute trials produced afterwards BW reduction during the 8-week chronic phase. These findings suggest that a behavioral effect over FI is obtained when the stimulation is turned on. This acute effect over FI disappears with time and a catabolic mechanism might be established producing finally the necessary energy consumption to provoke BW loss and BF reduction. Earlier studies show that bilateral lesions of the LH leads to acute reduction in FI, and animals that manage to survive this acute-phase lose weight, even when the FI reverted back to normal. 32 Finally, the increase in FI during off-stimulation after BW loss and rebound BW gain raises the question of how long the stimulation should continue to produce a stable BMI and possibly a 'new set point' for BF in the subjects.
Modification in locomotion
In our study, an increase in velocity during the acute phase was seen in three out four animals. Studies suggested that stimulationbound activity was an important contribution factor to decrease weight gain and FI during VMH stimulation .VMH stimulation has been shown to both increase metabolic rate and facilitate locomotors activity. 21 --33 In a study examining exercise metabolism, Vissing et al. 34 showed that exercise-induced increase in VMH activity may be regulated by the same CNS structures that also activate locomotion and substrate mobilization. Unfortunately, due to technical reasons, locomotion analysis in the chronic phase was not available in the study.
Hormonal and blood chemistry changes There was a concern about the possibility that hypothalamic ES could induce endocrinological side effects secondary to the secretion of releasing factors or by direct production of hormones. 35 --37 Besides hormones, the electrolytes and glucose might produce some undesirable side effects, like dehydration. 38 or diabetes. So, for evaluating the safety of the procedure, it was necessary to consider not only surgical tolerance or acute behavioral symptoms but also hormonal and laboratory tests. Conversely, laboratory measures can reveal mechanisms of BW reduction.
Some studies have established that effective ES of VMH produces a catabolic state associated to hyper-metabolism, which increases basal energy consumption 21 and could explain the BW and BF reduction. Opt, optic nerve; VMH, ventromedian hypothalamus; LH, lateral hypothalamus; MGP, medial globus pallidus; DMH, dorsomedial hypothalamic nucleus; ArcH, arcuatus nucleus; polx, fornix.
In the present study, electrolytes remained in the normal values, meaning probably that thirst centers were not compromised by the stimulation or at least could maintain compensatory mechanisms. In the literature, LH lesion and VMH ES in rodents were often accompanied with adipsia and hypernatremia during BW loss. 19, 22, 32, 39 During the trial, it was difficult to measure water intake for several technical reasons. Thus, measuring electrolytes provided at least an idea of the degree of dehydration.
An increase in the glycemia and FI, and a partial BW rebound was seen immediately after reduction in BW and BF following V3 80 Hz stimulation. Even though the levels of glucose increased, they remained in the normal range for Macaca. Obesity treatment usually reports rebound BW gain after successful BW loss 30, 40, 41 accompanied with hyperphagia 42 and a peak in serum glucose. 43 The fact that levels of glucose remained in the normal range even during the increase of FI indicate that pancreatic regulatory mechanism have probably compensated adequately. Future experiments should study this kind of peripheral responses induced by the ES in V3. VMH and possibly DMH ES do not produce direct secretion of hypothalamic releasing factors (like somatostatin or ACTH). However, it is well known that VMH stimulation is associated with an elevated sympathetic tonus, with an increase in the noradrenalin exchange rate in rodent's brown fat tissue. 44 Increased sympathetic tonus associated with increased metabolic basal energy consumption can lead to changes in some stress hormones. 34 Compensatory mechanisms might be at work in our study and help explain why hormones remained in reference levels. Additional measurements of metabolic rate should be done in order to explain the physiology of the hypothalamic weight loss.
Also, the intraventricular V3 approach to the stimulation rather than intraparenchymatous, might have been important for the prevention of spreading to neighboring areas. Some areas near VMH can effectively secrete hypothalamic releasing factors putting into risk the general health state of the implanted subject. Stimulation restricted to medial hypothalamic was probably the cause of non-involvement of those areas.
Finally, serum leptin did not follow a discernable pattern. BW loss due to food restriction is associated with a decrease in plasma leptin in mice and obese humans. However, authors have found that during BW loss, leptin does not follow exactly the BF in treated subjects. 45 Others have found that plasma leptin values per kg of BF do not change significantly with modest BW loss and it is associated with loss of peripheral (hip and girth) and abdominal rather than visceral fat stores. 46 We can presume that the decrease in BF was not as significant or persistent to produce variation in leptin levels in these non-obese individuals with no dietary restrictions.
Effects of ES parameters
Specific stimulation parameters were determined during the acute preliminary study. Frequency was the most determinant factor in FI changes and BW modulation. However, the precise values obtained differed from the ones usually applied in clinical situations, where functional inhibitions occur at 130 Hz 47 and activations, under 50 Hz. 48 --50 There are several possible explanations that can be provided. The localization of the electrodes in the vicinity of a complex area comprising not only grey nucleus but also fibers could explain at least the need of 'intermediate' frequencies (80 Hz). VMH nuclei are at proximity of antagonistic LH area that can be at least influenced by a low-or high-frequency stimulation.
Intermediate frequencies can theoretically stimulate VMH nuclei and be sufficiently high to provoke certain inhibition in orexigenic LHA. We can speculate then that this kind frequency is needed when antagonistic areas are connected as seen for instance, in simultaneous pedunculopontine nucleus and subthalamic nucleus stimulation. 51 A direct and specific effect could also explain the results. Probably this specific stimulation conveys information that helps stimulate behavioral and metabolic functions in ventral hypothalamic regions and produce BW loss.
Comparison in BW and BF content using different electrode geometry Some difference in BW reduction was seen in relation with electrode surface. Theoretical models favor small area of stimulation. Larger contact produce larger electrical fields capable of modulating antagonistic structures (like VMH and LH). In our case, the 1.5-mm electrode was able to stimulate medial parts of the VMH proximal to the 31-ventricle wall. In contrast, larger 3.5 mm contact could reach further lateral in the structures and made some antagonistic modulation in the LH. Future studies have to reduce the area of stimulation in order to be specific in this region.
Limitation of the study Great care was taken to avoid introducing other factors that could produce BW loss or gain other than brain stimulation. Food quantity and type was maintained exactly the same during the test periods. This lack of variation in diet could reduce palatability, and hence reduce FI and possible BW. 52, 53 However, the risk of introducing large variation in consumed calories and FI due to 'hedonic reward' in food ingestion prevented us from changing food types. 53 Another source of possible BW modulation could be stress caused by manipulation and anesthesia during trials. 54 Monkeys were anesthetized in order to measure BW, skinfolds and total BF via bioimpedance analysis. Measures were spaced 1 week apart and the dosage was regulated to avoid serious stress due to manipulation (cortisol levels remained normal).
The carry-on phenomenon, inherent to crossover studies, is also another possible source of error. WO periods were designed to diminish this effect. But limitations in time avoided the extension of the WO. Another limitation in the study is the effect of captivity on BW. Reduce mobility in animals and captivity usually has an anabolic effect. 55 As primates grow older, there is a tendency of accumulation in BF. 56 The use of a limited number of animals due to the nature of the study and the species is also a limitation for the statistical analysis and the extrapolation of the conclusion. Our model is also limited for the lack of access to obese monkeys. The use of obese monkeys was theoretically ideal, but difficult because the obese primates are difficult to obtain, usually old and often sick with concurrent pathologies, like diabetes or atherosclerosis. 57 Finally, the localization in the 3 V instead of directly in VMH could also be seen as a disadvantage. ES in a virtual cavity surrounded by different tissues influences the electrical fields and could theoretically spread current outside our desired targets. However, new research using computer models shows limited current spread in the tissue near the electrode contact in the 3 V wall. 58 
Safety issues
The effectiveness of DBS in the posterior hypothalamus has opened research pathways using the hypothalamic areas. 59 Unfortunately, some safety concerns remain. 60 These concerns have made us explore a new approach to reach these areas of the brain. Intraventricular DBS electrodes should theoretically have a risk comparable to the insertion of ventricular catheters. The use of only one electrode to stimulate bilaterally reduces the risk by half, preventing a double insertion in this difficult area.
Surgery was well tolerated in all animals with the usual BW loss in the post-operative period.
One of them had an infection in the implantable pulse generator that forced us to withdraw the battery. After total recovery, this animal was used as a sham. During the acute and chronic phase no behavioral changes were seen. Some stereotypical movements were observed in two monkeys, but were related to the long captivity periods in small cages. When the animals were put in bigger cages and in-pairs, the repetitive movements stopped.
Careful analysis of serum samples allowed us to conclude that stimulation did not induce modulation in vital plasma elements. The subjects were observed during a long period of time, almost 3 years from surgery to euthanasia. During this time, the monkeys tolerated the hardware well (implantable pulse generator and electrodes). The position of the tip of the electrode did not change, keeping VMH stimulated, without lesioning V3 walls or other areas. An associated lesion could have had an antagonistic effect over weight control.
In conclusion, the preliminary data obtained from this study shows a new approach to obesity in primates that could open the way to a possible future clinical application. New indications for DBS are flourishing, as our knowledge of the anatomo-physiology of diverse regions in the central nervous system develops. Also, the characteristics of reversibility and minimum lesion of the DBS allow researchers to explore new brain areas. Encouraging results in the modulation of the posterior hypothalamus in cluster headaches and the recent experiments in ES of VMH in obesity models in rodents have prompted investigation in this area. This is the first report of DBS reducing BW and BF content in non-human, non-obese primates. Reduction in BW and BF was not followed by remarkable side effects that could have prevented the future clinical application.
Also key in our study, the new approach of the intraventricular stimulation to reach medial structures has proved to be safe, stable in time and possibly more effective in modulation of circumventricular organs.
CONFLICT OF INTEREST
MEDTRONIC, the electrode manufacturer, provided a financial endowment to the laboratory INSERM, where this study was conducted, in the form of equipment and supplies, and they also provided support for attendance to conferences in the form of air tickets, accommodation and congresses fees to Dr Torres. There was not a direct implication in the study design, collection or analysis of data and decision to publish. Dr Chabardes has received support for attendance to conferences in the form of air tickets, accommodation and congresses fees from Medtronic. Dr Annaelle Devergnas has received support for attendance to conferences in the form of air tickets, accommodation and congresses fees from Medtronic.
